Similarly, a study comparing the molecular features of GBM with extracranial metastases compared to GBM without extracranial metastases, showed decreased MGMT methylation and more frequent TP53 mutations in patients with GBM with extracranial metastases.[24]. This evidence concerns the gene TP53 and glioblastoma.